BrainAurora Medical Technology Limited

脑动极光医疗科技有限公司

06681.HK

Develops software-based digital therapeutics and screening/assessment products for cognitive impairments caused by vascular, neurodegenerative and psychiatric disorders and child developmental deficiencies, with regulatory approvals in China and the EU.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Overlapping customers and suppliers
• Single product, business line or region
• Pricing policy and price changes
• Outsourced production (OEM / contract manufacturing)
• Business changes and acquisitions
• Losses and path to profitability
• Net current liabilities or net liabilities
• Cash burn and runway
• Working capital: receivables, prepayments and cash cycle
• Preferred shares and fair-value liabilities
• Investments and fair-value assets
• Non-IFRS measures and adjustments
• Non-recurring gains and losses
• Related-party transactions and balances
• Chapter 18A biotech